Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 2429-2434

  Brummel, Rachel ^a   Lenert, Petar ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL STIMULATION; CELL TYPE; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNOGLOBULIN PRODUCTION; LUPUS VULGARIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 13544254614     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.2429     Document Type: Article

References (41)

1. Gilkeson, G. S., J. P. Grudier, D. G. Karounos, and D. S. Pisetsky. 1989. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol. 142:1482.
2. Krieg, A. M. 1995. CpG DNA: a pathogenic factor in systemic lupus erythematosus. J. Clin. Immunol. 15:284.
3. Leadbetter, E. A., A. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Schlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
4. Viglianti, G. A., C. M. Lau, T. M. Hanley, B. A. Miko, M. J. Schlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837.
5. Yi, A. K., M. Chang, D. W. Peckham, A. M. Krieg, and R. F. Ashman. 1998. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 160:5898.
6. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
7. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
8. Lenert, P., A. Goeken, B. S. Handwerger, and R. F. Ashman. 2003. Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides. J. Clin. Immunol. 23:202.
9. Gilkeson, G. S., A. M. Pippen, and D. S. Pisetsky. 1995. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95:1398.
10. Anders, H. J., V. Vielhauer, V. Eis, Y. Linde, M. Kretzler, G. P. de Lema, F. Strutz, S. Bauer, M. Rutz, H. Wagner, et al. 2004. Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18:534.
11. 1 mice. Lupus 12:838.
12. Krug, A., S. Rothenfusser, V. Hornung, B. Jahrsdorfer, S. Blackwell, Z. K. Ballas, S. Endres, A. M. Krieg, and O. Hartmann. 2001. Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmocytoid dendritic cells. Eur. J. Immunol. 31:2154.
13. Verthelyi, D., K. J. Ishii, M. Gursel, F. Takeshita, and D. M. Klinman. 2001. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166:2372.
14. Vollmer, J., R. Weeratna, P. Payette, M. Jurk, C. Schetter, M. Laucht, T. Wader, S. Tluk, M. Liu, H. L. Davis, and A. M. Krieg. 2004. Characterization of three CpG oligonucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34:252.
15. Ballas, Z. K., A. M. Krieg, T. Warren, W. Rasmussen, H. L. Davis, M. Waldschmidt, and G. J. Weiner. 2001. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J. Immunol. 167:4878.
16. Gursel, M., D. Verthelyi, I. Gursel, K. J. Ishii, and D. M. Klinman. 2002. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukocyte Biol. 71:813.
17. Verthelyi, D., and R. A. Zeuner. 2003. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24:519.
18. Hemmi, H., T. Kaisho, K. Takeda, and S. Akira. 2003. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effect of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170:3059.
19. An, H., H. Xu, Y. Yu, M. Zhang, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, Z. Qin, and X. Cao. 2002. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-κB, ERK and p38 MAPK signal pathways. Immunol. Lett. 81:165.
20. Lenert, P., W. Rasmussen, R. F. Ashman, and Z. Ballas. 2003. Structural characterization of the inhibitory DNA motif for the type A(D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol. 22:621.
21. Moore, K. W., R. de Wall Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
22. Ballas, Z. K., W. L. Rasmussen, and A. M. Krieg. 1996. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1840.
23. Hartmann, G., J. Battiany, H. Poeck, M. Wagner, M. Kerkmann, N. Lubenow, S. Rothefusser, and S. Endres. 2003. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmocytoid dendritic cells. Eur. J. Immunol. 33:1633.
24. Krieg, A. M., T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, S. Short, and H. Davis. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95:12631.
25. Lenert, P., L. Stunz, A. K. Yi, A. M. Krieg, and R. F. Ashman. 2001. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev. 11:247.
26. Zeuner, R. A., K. J. Ishii, M. J. Lizak, I. Gursel, H. Yamada, D. M. Klinman, and D. Verthelyi. 2002. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum. 46:2219.
27. Lenert, P., A. K. Yi, A. M. Krieg, L. L. Stunz, and R. F. Ashman. 2003. Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells. Antisense Nucleic Acid Drug Dev. 13:143.
28. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936.
29. Yin, Z., G. M. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff, M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169:2148.
30. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Immunol. 2:323.
31. Martin, F., and J. F. Keamey. 2000. B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175:70.
32. MacLennan, I. C., H. Bazin, D. Chassoux, D. Gray, and J. Lortan. 1985. Comparative analysis of the development of B cells in marginal zones and follicles. Adv. Exp. Med. Biol. 186:139.
33. Mond, J. J., Q. Vos, A. Lees, and C. M. Snapper. 1995. T-cell-independent antigens. Curr. Opin. Immunol. 7:349.
34. Chen, X., F. Martin, K. A. Forbush, R. M. Perlmutter, and J. F. Kearney. 1997. Evidence of selection of a population of multireactive B cells into the splenic marginal zone. Int. Immunol. 9:27.
35. Kenny, J. J., L. J. Rezanka, A. Lustig, R. T. Fischer, J. Yoder, S. Marshall, and D. L. Longo. 2000. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 164:4111.
36. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zones that express dual receptors. J. Exp. Med. 195:181.
37. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886.
38. 1 mice. Clin. Immunol. 94:51.
39. Groom, J., S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock, P. Schneider, J. Tschopp, T. G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLys overexpression and altered B-cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:59.
40. Sano, H., and C. Morimoto. 1982. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J. Immunol. 128:1341.
41. Lenert, P., R. Brummel, E. H. Field, and R. F. Ashman. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. In press.